These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

691 related items for PubMed ID: 7841545

  • 1. Increased sensitivity of tumor-bearing host macrophages to interleukin-10: a counter-balancing action to macrophage-mediated suppression.
    Alleva DG, Burger CJ, Elgert KD.
    Oncol Res; 1994; 6(4-5):219-28. PubMed ID: 7841545
    [Abstract] [Full Text] [Related]

  • 2. Promotion of macrophage-stimulated autoreactive T cell proliferation by interleukin-10: counteraction of macrophage suppressor activity during tumor growth.
    Alleva DG, Elgert KD.
    Immunobiology; 1995 Feb; 192(3-4):155-71. PubMed ID: 7782092
    [Abstract] [Full Text] [Related]

  • 3. Tumor growth changes responsiveness to and production of granulocyte-macrophage colony-stimulating factor during recognition of self MHC class II molecules.
    Walker TM, Burger CJ, Elgert KD.
    Oncol Res; 1992 Feb; 4(11-12):455-65. PubMed ID: 1299376
    [Abstract] [Full Text] [Related]

  • 4. Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-alpha production. Role of tumor-derived IL-10, TGF-beta, and prostaglandin E2.
    Alleva DG, Burger CJ, Elgert KD.
    J Immunol; 1994 Aug 15; 153(4):1674-86. PubMed ID: 8046239
    [Abstract] [Full Text] [Related]

  • 5. Tumor growth changes the contribution of granulocyte-macrophage colony-stimulating factor during macrophage-mediated suppression of allorecognition.
    Walker TM, Yurochko AD, Burger CJ, Elgert KD.
    Immunobiology; 1992 Sep 15; 185(5):427-39. PubMed ID: 1452214
    [Abstract] [Full Text] [Related]

  • 6. Fibrosarcoma-induced increase in macrophage tumor necrosis factor alpha synthesis suppresses T cell responses.
    Alleva DG, Askew D, Burger CJ, Elgert KD.
    J Leukoc Biol; 1993 Aug 15; 54(2):152-60. PubMed ID: 8360594
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Paclitaxel enhances macrophage IL-12 production in tumor-bearing hosts through nitric oxide.
    Mullins DW, Burger CJ, Elgert KD.
    J Immunol; 1999 Jun 01; 162(11):6811-8. PubMed ID: 10352302
    [Abstract] [Full Text] [Related]

  • 10. Tumour growth causes suppression of autoreactive T-cell proliferation by disrupting macrophage responsiveness to interferon-gamma.
    Alleva DG, Burger CJ, Elgert KD.
    Scand J Immunol; 1994 Jan 01; 39(1):31-8. PubMed ID: 7904773
    [Abstract] [Full Text] [Related]

  • 11. Interferon-gamma reduces tumor-induced Ia- macrophage-mediated suppression: role of prostaglandin E2, Ia, and tumor necrosis factor-alpha.
    Alleva DG, Burger CJ, Elgert KD.
    Immunopharmacology; 1993 Jan 01; 25(3):215-27. PubMed ID: 8354638
    [Abstract] [Full Text] [Related]

  • 12. Induction of macrophage suppressor activity by fibrosarcoma-derived transforming growth factor-beta 1: contrasting effects on resting and activated macrophages.
    Alleva DG, Walker TM, Elgert KD.
    J Leukoc Biol; 1995 Jun 01; 57(6):919-28. PubMed ID: 7790775
    [Abstract] [Full Text] [Related]

  • 13. Tumor-induced macrophage tumor necrosis factor-alpha production suppresses autoreactive T cell proliferation.
    Alleva DG, Burger CJ, Elgert KD.
    Immunobiology; 1993 Aug 01; 188(4-5):430-45. PubMed ID: 8244447
    [Abstract] [Full Text] [Related]

  • 14. Tumor growth alters T cell and macrophage production of and responsiveness to granulocyte-macrophage colony-stimulating factor: partial dysregulation through interleukin-10.
    Walker TM, Burger CJ, Elgert KD.
    Cell Immunol; 1994 Apr 01; 154(1):342-57. PubMed ID: 8131207
    [Abstract] [Full Text] [Related]

  • 15. Tumor modulation of autoreactivity: decreased macrophage and autoreactive T cell interactions.
    Yurochko AD, Burger CJ, Elgert KD.
    Cell Immunol; 1990 Apr 15; 127(1):105-19. PubMed ID: 2138515
    [Abstract] [Full Text] [Related]

  • 16. Modulation of alloreactivity by Mac-1+, -2+, and -3+ macrophages from normal and tumor-bearing hosts: flow cytofluorometrically separated macrophages.
    Askew D, Burger CJ, Elgert KD.
    Immunobiology; 1990 Dec 15; 182(1):1-10. PubMed ID: 2151512
    [Abstract] [Full Text] [Related]

  • 17. Granulocyte-macrophage colony-stimulating factor activates macrophages derived from bone marrow cultures to synthesis of MHC class II molecules and to augmented antigen presentation function.
    Fischer HG, Frosch S, Reske K, Reske-Kunz AB.
    J Immunol; 1988 Dec 01; 141(11):3882-8. PubMed ID: 3141506
    [Abstract] [Full Text] [Related]

  • 18. Migration inhibitory factor induces killing of Leishmania major by macrophages: dependence on reactive nitrogen intermediates and endogenous TNF-alpha.
    Jüttner S, Bernhagen J, Metz CN, Röllinghoff M, Bucala R, Gessner A.
    J Immunol; 1998 Sep 01; 161(5):2383-90. PubMed ID: 9725234
    [Abstract] [Full Text] [Related]

  • 19. Macrophage-derived prostaglandin E modulation of the mixed-lymphocyte reaction: an anomaly of increased production and decreased T-cell susceptibility during tumor growth.
    Denbow CJ, Conroy JM, Elgert KD.
    Cell Immunol; 1984 Mar 01; 84(1):1-13. PubMed ID: 6230157
    [Abstract] [Full Text] [Related]

  • 20. IL-10 inhibits mitogen-induced T cell proliferation by selectively inhibiting macrophage costimulatory function.
    Ding L, Shevach EM.
    J Immunol; 1992 May 15; 148(10):3133-9. PubMed ID: 1578140
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.